Etodolac
- Product NDC
- 43353-294
- 11-digit product format
- 433530294
- Labeler code
- 43353
- Product ID
- 43353-294_f7a2760f-2274-412b-8dc6-111f547e7e03
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Etodolac
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA075419
- Marketing category
- ANDA
- Marketing start
- 2017-01-05
- Marketing end
- 0000-00-00
- Substance
- ETODOLAC
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-294 | ETODOLAC (ETODOLAC) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20171021_d8edfe71-a186-4ee1-9287-d4f69fd79da4.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-294-53 | 43353029453 | 60 CAPSULE in 1 BOTTLE (43353-294-53) | 60 capsule | 2017-03-17 | 0000-00-00 | No | No | Current |
| 43353-294-60 | 43353029460 | 90 CAPSULE in 1 BOTTLE (43353-294-60) | 90 capsule | 2017-04-04 | 0000-00-00 | No | No | Current |